HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italy's Health Ministry Sets Up Supplements Committee To Improve Oversight Of Growing Sector

Executive Summary

Italy has set up a new committee to oversee its booming food supplements market with a remit of consumer protection and advising on proportionate regulation.

You may also be interested in...



Clasado Begins European Expansion Of Bimuno Prebiotic With Italy And San Marino

Prebiotic manufacturer Clasado has struck a deal to bring its Bimuno brand to Europe's most liberal biotics market, Italy, as well as neighboring San Marino. It's the first move in an international expansion strategy which will eventually take Clasado to the US and Asia.

Is The Tide Turning For EU Prebiotics And Probiotics Regulation?

More EU countries than you might think allow the terms "prebiotic" and "probiotic" on food supplement labels, suggests a survey from consultancy firm Sandwalk Bioventures. HBW Insight speaks to Sandwalk's managing director, Luis Gosalbez, about a possible move towards liberalization in the region among member states, as well as a way forward for EU regulators lagging behind this localized movement. 

Italy's Supplements Market Gets Big Boost From COVID After Solid 2019

Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year. The strong start to 2020 builds on a solid 2019 for the Italian supplements market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel